FMO5 and Alzheimer disease: Specific upregulation of NADPH oxidase expression and activity was found in the temporal gyri of mild cognitive impairment patients, not in late-stage AD patients, suggesting that NADPH oxidase-associated generation of ROS is implicated in the early pathogenesis of AD.